Literature DB >> 7116076

Mania secondary to procyclidine ("Kemadrin") abuse.

J Coid, J Strang.   

Abstract

A case of procyclidine abuse is described in which the clinical presentation was indistinguishable from mania. The patient was a long-standing poly-drug abuser and was obtaining the drugs from medical sources. Controlled exposure on the ward to drugs of abuse, including a double-blind comparison with placebo, confirmed that procyclidine caused a manic response in this patient.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7116076     DOI： 10.1192/bjp.141.1.81

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  7 in total

Review 1.  Acetylcholine and affective disorder.

Authors:  S S Leong; W A Brown
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 2.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

3.  Anticholinergic drug abuse: a common problem?

Authors:  G P Pullen; N R Best; J Maguire
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-08

Review 4.  Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature.

Authors:  D L Sultzer; J L Cummings
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 5.  Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics.

Authors:  Stephanie C Dulawa; David S Janowsky
Journal:  Mol Psychiatry       Date:  2018-08-17       Impact factor: 15.992

Review 6.  Misuse of Anticholinergic Medications: A Systematic Review.

Authors:  Stefania Chiappini; Alessio Mosca; Andrea Miuli; Francesco Maria Semeraro; Gianluca Mancusi; Maria Chiara Santovito; Francesco Di Carlo; Mauro Pettorruso; Amira Guirguis; John Martin Corkery; Giovanni Martinotti; Fabrizio Schifano; Massimo Di Giannantonio
Journal:  Biomedicines       Date:  2022-02-01

7.  Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Veronica Antipova; Carsten Holzmann; Alexander Hawlitschka; Martin Witt; Andreas Wree
Journal:  Toxins (Basel)       Date:  2021-07-20       Impact factor: 4.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.